Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate/Severe Atopic Dermatitis”

436 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 436 results

Testing effectiveness (Phase 2)Study completedNCT03921411
What this trial is testing

A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Galderma R&D 20
Large-scale testing (Phase 3)Study completedNCT05633355
What this trial is testing

Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 187
Large-scale testing (Phase 3)Not Yet RecruitingNCT06956196
What this trial is testing

Study of Stapokibatrt in Children Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Keymed Biosciences Co.Ltd 240
Testing effectiveness (Phase 2)Study completedNCT05715320
What this trial is testing

Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Keymed Biosciences Co.Ltd 160
Testing effectiveness (Phase 2)Study completedNCT06283550
What this trial is testing

Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

Who this might be right for
Chronic Hand Eczema
Innovaderm Research Inc. 82
Early research (Phase 1)Ended earlyNCT04211415
What this trial is testing

Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Daiichi Sankyo Co., Ltd. 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT06094179
What this trial is testing

Evaluate the Safety, Tolerability of BAT6026

Who this might be right for
Dermatitis, Atopic
Bio-Thera Solutions 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175233
What this trial is testing

Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Jiangsu Simcere Pharmaceutical Co., Ltd. 184
Large-scale testing (Phase 3)Study completedNCT04760314
What this trial is testing

Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Dermatitis, AtopicDermatitisEczema+2 more
Eli Lilly and Company 286
Large-scale testing (Phase 3)Study completedNCT05355818
What this trial is testing

Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema

Who this might be right for
Chronic Hand Eczema
LEO Pharma 98
Testing effectiveness (Phase 2)Study completedNCT05469464
What this trial is testing

Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS)

Who this might be right for
Atopic DermatitisSkin Diseases
UNION therapeutics 235
Large-scale testing (Phase 3)Study completedNCT04587453
What this trial is testing

Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma 106
Post-approval studies (Phase 4)Study completedNCT04718870
What this trial is testing

Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis

Who this might be right for
Dermatitis Atopic
Sanofi 41
Testing effectiveness (Phase 2)Study completedNCT03703102
What this trial is testing

Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Kyowa Kirin, Inc. 274
Large-scale testing (Phase 3)Looking for participantsNCT06311682
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma 195
Not applicableNot Yet RecruitingNCT06463353
What this trial is testing

Clinical Study of Trilinolein Cream for Prevention of Relapse in Remission of Moderate-to-severe Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Shanghai Yueyang Integrated Medicine Hospital 376
Large-scale testing (Phase 3)Looking for participantsNCT06239311
What this trial is testing

Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

Who this might be right for
Moderate to Severe Atopic Dermatitis
medac GmbH 277
Large-scale testing (Phase 3)Study completedNCT04871711
What this trial is testing

Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema

Who this might be right for
Chronic Hand Eczema
LEO Pharma 487
Testing effectiveness (Phase 2)Study completedNCT05656911
What this trial is testing

Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Bayer 77
Very early researchStudy completedNCT05891119
What this trial is testing

Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amgen 21
Load More Results